CAMBRIDGE, Mass., Oct. 24, 2011 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that Sandoz has confirmed the launch of an authorized generic version of Lovenox in the fourth quarter of 2011.
